BCAX · Bicara Therapeutics Inc.

NasdaqHealthcareBiotechnology

Bicara Therapeutics Inc Is A Clinical-Stage Biopharmaceutical Company Bringing Transformative Bifunctional Therapies To Patients With Solid Tumors. Its Program Ficerafusp Alfa Is A Bifunctional Antibody That Combines Two Clinically Validated Targets, An Epidermal Growth Factor Receptor, Or Egfr, Directed Monoclonal Antibody With A Domain That Binds To Human Transforming Growth Factor Beta, Or Tgf-B. The Company'S Goal Is To Build A Fully Integrated, Commercial-Stage Biopharmaceutical Company That Develops Important Therapies For People Living With Cancer, Starting With Ficerafusp Alfa.

HealthcareNasdaqUSMid Float

FLOAT

43.2M

FREE FLOAT %

65%

SHARES O/S

66.2M

MARKET CAP

$1.13B

EXCHANGE

Nasdaq

COUNTRY

BCAX Catalyst History

No catalysts recorded for BCAX yet

Day Trader Sniper hasn't classified a publishable catalyst for BCAX yet. New events appear here as they're scored.

Be early on the next BCAX spark.

Day Trader Sniper alerts you the instant a setup like this triggers.

How it works Download Free →

Every Second Counts.Don't Trade Without a Real-Time sparker alert.

BCAX · Bicara Therapeutics Inc.

BCAX Catalyst History

Every Second Counts.
Don't Trade Without a Real-Time sparker alert.